Bicycle Therapeutics (BCYC) Deferred Taxes (2022 - 2026)
Bicycle Therapeutics (BCYC) reported Deferred Taxes of -$241000.0 for Q1 2026, up 81.69% on a YoY basis from -$132645.8 in Q1 2025, and down 128.59% quarter-over-quarter from $843000.0 in Q4 2025.
Bicycle Therapeutics (BCYC) Deferred Taxes (2022 - 2026) Analysis & Trends
Bicycle Therapeutics has reported Deferred Taxes for 5 years, with the latest figure at -$241000.0 in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes rose 81.69% year-over-year to -$241000.0; the trailing twelve-month figure through Mar 2026 stood at $225000.0 (up 103.9% YoY), and the FY2025 full-year result was -$850000.0, up 83.74% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$241000.0, down from $843000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $7.3 million in Q3 2023, with the low at -$3.3 million in Q3 2024.
- Historically, Deferred Taxes has averaged -$418941.2 across 5 years, with a median of -$767000.0 in 2024.
- Annual changes were most pronounced in 2023 — Deferred Taxes jumped 810.06% — and 2024, when it tumbled 266.67%.
- Bicycle Therapeutics' Deferred Taxes stood at -$1.5 million in 2022, then surged by 80.83% to -$282000.0 in 2023, then plunged by 266.67% to -$1.0 million in 2024, then surged by 181.53% to $843000.0 in 2025, then slumped by 128.59% to -$241000.0 in 2026.
- The last three Deferred Taxes figures came in at -$241000.0 (Q1 2026), $843000.0 (Q4 2025), and -$46000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | -241,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -241,000.00 |
| Dec 31, 2025 | 843,000.00 |
| Sep 30, 2025 | -46,000.00 |
| Jun 30, 2025 | -331,000.00 |
| Mar 31, 2025 | -1.32 Mn |
| Dec 31, 2024 | -1.03 Mn |
| Sep 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | -110,000.00 |
| Mar 31, 2024 | -767,000.00 |
| Dec 31, 2023 | -282,000.00 |
| Sep 30, 2023 | 7.27 Mn |
| Jun 30, 2023 | -1.58 Mn |
| Mar 31, 2023 | -2.11 Mn |
| Dec 31, 2022 | -1.47 Mn |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -868,000.00 |
| Mar 31, 2022 | -748,000.00 |